Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel

Suresh Vedantham1, Susan R Kahn2, Samuel Z Goldhaber3

  • 1Washington University in St Louis, St Louis, MO, USA vedanthams@mir.wustl.edu.

Insights

Advanced post-thrombotic syndrome (PTS) and chronic iliac vein obstruction significantly limit patients. A planned clinical trial will evaluate endovascular therapy to improve treatment options and quality of life for these individuals.

Area of Science:

  • Vascular Medicine
  • Interventional Cardiology
  • Clinical Trial Design

Background:

  • Advanced post-thrombotic syndrome (PTS) and chronic iliac vein obstruction cause severe physical limitations and reduced quality of life.
  • Current treatment options for these conditions lack robust evidence-based support.
  • Early research indicates potential benefits of endovascular therapy for iliac vein obstruction and venous valvular reflux.

Framework:

  • A multidisciplinary expert panel convened to design a multicenter randomized controlled clinical trial.
  • The trial aims to rigorously evaluate the efficacy of endovascular therapy for advanced PTS.
  • The panel's findings will guide the development of NIH-sponsored research.

Implementation:

  • The proposed trial will focus on imaging-guided, catheter-based endovascular interventions.
  • Key endpoints will include the elimination of iliac vein obstruction and saphenous venous valvular reflux.
  • Patient-reported outcomes, including quality of life and physical limitations, will be assessed.

Implications:

  • Successful validation of endovascular therapy could establish a new evidence-based treatment standard for advanced PTS.
  • Improved treatment strategies may significantly enhance the physical function and quality of life for affected patients.
  • This research is expected to advance the understanding and management of chronic venous diseases.

Related Concept Videos